Michael Kutryk

MD, FRCPC, PhD

Scientist, Keenan Research Centre for Biomedical Science

Recent Publications

  1. McKavanagh, P, Zawadowski, G, Ahmed, N, Kutryk, M. The evolution of coronary stents. Expert Rev Cardiovasc Ther. 2018;16 (3):219-228. doi: 10.1080/14779072.2018.1435274. PubMed PMID:29381087 .
  2. Gu, X, Zhang, Q, Sun, H, Fei, J, Zhang, X, Kutryk, MJ et al.. Transcatheter Closure Versus Repeat Surgery for the Treatment of Postoperative Left-to-Right Shunts: A Single Center 15-Year Experience. Cardiol Res. 2017;8 (6):286-292. doi: 10.14740/cr629e. PubMed PMID:29317971 PubMed Central PMC5755660.
  3. Gu, X, Zhang, Q, Sun, H, Fei, J, Zhang, X, Kutryk, MJ et al.. Transcatheter closure of calcified patent ductus arteriosus in older adult patients: Immediate and 12-month follow-up results. Congenit Heart Dis. 2017;12 (3):289-293. doi: 10.1111/chd.12437. PubMed PMID:27874259 .
  4. Stone, GW, Sabik, JF, Serruys, PW, Simonton, CA, Généreux, P, Puskas, J et al.. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N. Engl. J. Med. 2016;375 (23):2223-2235. doi: 10.1056/NEJMoa1610227. PubMed PMID:27797291 .
  5. Ting, R, Tejpal, A, Finken, L, Fisher, M, Lefkowitz, C, Parthasarathy, H et al.. Repatriation to referral hospital after reperfusion of STEMI patients transferred for primary percutaneous coronary intervention: Insights of a Canadian regional STEMI care system. Am. Heart J. 2016;177 :145-52. doi: 10.1016/j.ahj.2016.04.017. PubMed PMID:27297860 .
  6. Lu, J, Bagai, A, Buller, C, Cheema, A, Graham, J, Kutryk, M et al.. Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program. Am. Heart J. 2016;173 :126-33. doi: 10.1016/j.ahj.2015.10.027. PubMed PMID:26920605 .
  7. Mukovozov, I, Huang, YW, Zhang, Q, Liu, GY, Siu, A, Sokolskyy, Y et al.. The Neurorepellent Slit2 Inhibits Postadhesion Stabilization of Monocytes Tethered to Vascular Endothelial Cells. J. Immunol. 2015;195 (7):3334-44. doi: 10.4049/jimmunol.1500640. PubMed PMID:26297762 .
  8. Granton, J, Langleben, D, Kutryk, MB, Camack, N, Galipeau, J, Courtman, DW et al.. Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial. Circ. Res. 2015;117 (7):645-54. doi: 10.1161/CIRCRESAHA.114.305951. PubMed PMID:26195220 .
  9. Li, J, Zhang, Q, Li, D, An, Y, Kutryk, MB. Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis. J. Cardiovasc. Pharmacol. Ther. 2015;20 (3):322-9. doi: 10.1177/1074248414558518. PubMed PMID:25412893 .
  10. Mrówczyński, W, Rungatscher, A, Buchegger, F, Tille, JC, Namy, S, Ratib, O et al.. Biological effects of anti-CD34-coated ePTFE vascular grafts. Early in vivo experimental results. Kardiochir Torakochirurgia Pol. 2014;11 (2):182-90. doi: 10.5114/kitp.2014.43848. PubMed PMID:26335112 PubMed Central PMC4283864.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
  • Staff Physician, St. Michael’s Hospital
  • Assistant Professor, University of Toronto
X